(Q80148278)
Statements
Preclinical pharmacokinetics and in vitro metabolism of dasatinib (BMS-354825): a potent oral multi-targeted kinase inhibitor against SRC and BCR-ABL (English)
Amrita V Kamath
Jian Wang
Francis Y Lee
Punit H Marathe